Tumstatin was reported to inhibit bFGF-induced proliferation of HUVECs, and melanoma cells, besides inducing apoptosis in endothelial cells and inhibiting neovascularization in matrigel plugs and in vivo tumor growth in different murine cancer types [22,24-27]. The gene discussed is FGF2; the disease is melanoma.